About Gloucester Pharmaceuticals

Company Website: http://www.gloucesterpharma.com

Gloucester Pharmaceuticals is a biopharmaceutical company owned by Celgene that acquires clinical-stage oncology drug candidates with the goal of advancing them through regulatory approval and commercialization. Gloucester's first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of hematological malignancies. The Company retains worldwide exclusive rights to romidepsin, an oncology candidate within a new class of anti-cancer agents known as histone deacetylase (HDAC) inhibitors. Preclinical studies suggest that romidepsin is a potent inhibitor of Class I, Class II and Class IV HDACs.

Current Openings

Gloucester Pharmaceuticals has no jobs listed. Checkout our job board for opportunities at top VC-backed startups.